AGP Picks
View all

America Latina Times
Provided by AGP

America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 10, 2026

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease
Jun. 10, 2026

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease

Indeterminate GlobeNewswire
Brunswick Exploration Increases Anais Strike Extent to Over 350 Meters
Jun. 10, 2026

Brunswick Exploration Increases Anais Strike Extent to Over 350 Meters

Indeterminate GlobeNewswire
Ero Confirms High-Grade Continuity and Extends Known Mineralization at Furnas with Significant New Step-Out Intercepts
Jun. 10, 2026

Ero Confirms High-Grade Continuity and Extends Known Mineralization at Furnas with Significant New Step-Out Intercepts

Indeterminate GlobeNewswire
Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment
Jun. 10, 2026

Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment

Indeterminate GlobeNewswire
Italfarmaco annonce l’acceptation du dépôt et l’examen prioritaire par Santé Canada pour la présentation de drogue nouvelle du givinostat dans le traitement de la dystrophie musculaire de Duchenne
Jun. 10, 2026

Italfarmaco annonce l’acceptation du dépôt et l’examen prioritaire par Santé Canada pour la présentation de drogue nouvelle du givinostat dans le traitement de la dystrophie musculaire de Duchenne

Indeterminate GlobeNewswire
Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate
Jun. 10, 2026

Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate

Indeterminate GlobeNewswire
CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome
Jun. 10, 2026

CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome

Indeterminate GlobeNewswire
Cytospire Therapeutics Appoints Samit Hirawat, M.D., as Non-Executive Director
Jun. 10, 2026

Cytospire Therapeutics Appoints Samit Hirawat, M.D., as Non-Executive Director

Indeterminate GlobeNewswire
Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery
Jun. 10, 2026

Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery

Indeterminate GlobeNewswire
Bitget Wallet Opens Tokenized Stock and RWA Trading to API Partners
Jun. 10, 2026

Bitget Wallet Opens Tokenized Stock and RWA Trading to API Partners

Indeterminate GlobeNewswire
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
Jun. 10, 2026

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering

Indeterminate GlobeNewswire
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
Jun. 10, 2026

Parabilis Medicines Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

America Latina Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.